Volume 17, Issue 7 (July 2019 2019)                   IJRM 2019, 17(7): 473-480 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Keshavarz L, Yavarian M. The association of Q472H variant in the KDR gene with recurrent pregnancy loss in Southern Iran: A case-control study. IJRM 2019; 17 (7) :473-480
URL: http://ijrm.ir/article-1-1579-en.html
1- Department of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, Iran.
2- Shiraz Nephron-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran , yavarian@sums.ac.ir
Full-Text [PDF 416 kb]   (883 Downloads)     |   Abstract (HTML)  (2389 Views)
Full-Text:   (430 Views)
1. Introduction
Three or more consecutive pregnancy losses before the 20th wk of gestation is referred to as recurrent spontaneous abortion (RSA) (1). This is a reproductive issue that challenges approximately 1% of women at the reproductive age, and the causes of about half of the RSA cases remain undecided (2-4). Chromosomal abnormalities are one of the main causes of spontaneous abortion (5) followed by molecular genetic defect like inherited thrombophilia. Non-genetic causes including abnormalities of the uterus, dysfunctions of the endocrine system, autoimmune diseases, as well as nutritional and environmental parameters are also mentioned on the etiology of RSA (6, 7). Vascular endothelial growth factor (VEGF) as a main angiogenic factor has a primary role
in the regulation of endothelial cell proliferation.
It also acts as a survival factor for endothelial cells during both physiological and tumor angiogenesis. Furthermore, VEGF is a vasodilator that increases vascular permeability and has antiapoptosis properties (8, 9). VEGF is a critical factor in the early stages of pregnancy such as oocyte maturation and the growth of trophoblast.
It is also important in the implantation and subsequent development of the embryo. Moreover, the angiogenesis during placenta development as well as the formation of maternal and fetal blood vessels in the uterus is related to VEGF (10, 11). There are two tyrosine kinase receptors for VEGF, VEGF receptor 1 (VEGFR1/FLT1) and VEGF receptor 2 (VEGFR2/FLK1/KDR) (12). These two VEGF receptors -a signal-transducing receptorcarries Kinase domain, which has also been stated to be associated with RSA in report, possibly resulting from the effects on the angiogenesis of placenta via the VEGF-KDR pathway (11, 13, 14). Placental angiogenesis is important for the successful development of a fetus considering the influences on the transplacental exchange between maternal and fetal blood flow (15). In human during the early pregnancy, the KDR gene expresses has critical roles on normal physiology or physiopathology of placental precursor cells.
It has influence on the vasculogenic as well as angiogenic of proliferative endothelial cells and altered quality of its migration as well (16, 17).
Experimentally in the KDR gene knockout, mice embryonic death occurs due to defects in the fetal and placental vasculogenesis and angiogenesis (18). A number of single nucleotide polymorphisms (SNPs) in the KDR gene have been reported that have effect on the pathogenicity of several diseases including RSA, lung and breast cancers, coronary heart disease, as well as cerebrovascular disorder (19). These SNPs include – 604T/C at the KDR promoter region alternate/affect promoter activity, 1192G/A (rs2305948) in exon 7 with the Val297Ile substitution, and 1719A/T (rs1870377) in exon 11 with the Gln472His substitution effects on the function of VEGF/KDR pathway (20, 21).
In Iran, there are at least two studies regarding the KDR gene polymorphism and RSA (22, 23).
These reports have been done on the mother’s blood and the effect of paternal imprint is mistreated.
In this study, the 1719A/T in the exon 11 of KDR gene of fetal as a risk factor for RSA in our area has been analyzed.
2. Materials and Methods
2.1. Subjects
In total, 50 samples of embryonic tissue (obtained from fetuses) and 50 umbilical cord blood of newborn babies were selected randomly from the Shiraz Hafez Hospital ( Jan-May 2017). The fetus selected from mothers who had experienced  at least two consecutive miscarriages earlier and controls from mothers had at least one full-term infants. These groups Maternal control group and cases group were matched by ethnicity and age.
All subjects with underlying diseases or abnormal laboratory data including immunologic, infection, or abnormal karyotype were excluded from the
controls.
2.2. Genetic analysis
Genomic DNA from embryonic tissue as well as whole EDTA blood was extracted using PureLink genomic DNA kit (Life Technologies, CA) according to the manufacturer instructions. The quantity and quality of extracted DNA were checked by Nanodrop spectrophotometer (BioTek company) and 0.8% agarose gel electrophoresis, respectively. All DNA samples were stored at -20°C until further analysis. Genetic variations for Gln472His (A/T) SNP was analyzed by LC-Green (Idaho Technology, Salt Lake City, Utah, USA) high-resolution melting (HRM) curve method following the PCR amplification (Qiagen company).
2.3. Primers sequences
Sequence of used primers for Gln472His (A/T) polymorphism genotyping is: Forward primer: (5’-GGAAGTCCTCCACACTTCTCC-3’) Reverse primer: 
(5’-GTACCATGGTAGGCTGCGTT-3’) 2.4. PCR reactions and melting analysis PCR was performed in 8 μl volum with 20 ng of template DNA, 1.5 mM MgCl2, 265 μM dNTP, 10 pico mol of forward and reverse primers, and 0.8X LC-Green Plus (Idaho Technology, Salt Lake City, Paisley, Scotland) is used for PCR.
PCR cycling conditions included an initial activation step at 95°C for 5 min followed by 40 cycles of denaturation for 10 s at 95°C and annealing/extension step for 30 s at 55°C to allow for fluorescence data acquisition on the green channel. A 192 bp PCR product is accomplished by HRM analysis in the range of 65-95°C and 0.1°C rising at each cycle. All test run with null template control (NTC) and control of known genotype on each course. A Sanger sequence confirmed
sample is used as control in HRM-Realtime PCR and 20 samples (case and control) were randomly selected and checked by sequencing for reconformation.
2.5. Ethical consideration
The research was performed whit the approval of the Ethics Committee of the Islamic Azad University, Dehaghan Branch (Approval No.
IR.IAU.DEHAGAN.REC.1397.002), a written consent was obtained from all the mother whose fetuses or cord bloods were used.
2.6. Statistical analysis
Statistical analysis performed by using SPSS software version 18.0 statistical program (Statistical Package for the Social Sciences, SPSS Inc., Chicago, Illinois, USA). Chi-square test and logistic regression analysis were used to analyze the differences between the abortion materials and control subjects. Corresponding genotype and allele frequencies between fetal cases and control group is compered. For the risk assessment of the KDR SNP, Odds ratio (OR) and p-values were used.
3. Results
Real-time PCR and Melting Analysis technique, Gln472His (A/T) polymorphism of the KDR gene were evaluated in study groups (50 abortion materials and 50 control subjects) (Figure 1), and the results were compared between both the fetus and control groups. The mean age of the mothers of case group was 32.07 ± 4.23 yr, and the mean age of the mothers of controls was 33.49 ± 3.80 yr. The other diseases that may contribute with pregnancy outcome exclude in
the study groups. Demographic characteristics and clinical profiles of RSA patients and controls are summarized in Table I for comparison. For the controls and RSA patients, genotype and allele frequencies of polymorphism KDR Gln472His (A/T) are listed in Table II. All genotype distributions among the study patients were in Hardy–Weinberg equilibrium. In the statistical analysis, AT genotype and T-allele in dominance were found as risk factors for abortion in case group. AT genotype represents and T-allele in dominance represents 2.824 and 2.447-fold risk reactively in fetus group compared with the control group. The difference in
genotypes frequencies between fetus and control group was not statistically significant (p > 0.05) (Table II).

Table I. Demographic data of cases and controls


Table II. Genotype frequencies of Gln472His polymorphism of the KDR gene among controls and RSA patients



Figure 1. HRM profiles of the product 10–192 bp of the KDR Gln472His polymorphism.
4. Discussion
Far province is inhabitancy of multi-ethnic group with distinct genetic property. Genetic variance play a crucial role on the cause of morbidity and mortality of fetus.
The implantation of the embryo is a vital stage in reproduction. It requires an appropriate communication between the mother as a receptive endometrium and the embryo. Various factors affect endometrium which can be summarized as follows various cytokines, growth factors, and adhesion molecules (24-26). Among these factors, VEGF and its receptors, VEGF receptor 1 (VEGFR1/ Flt1) and VEGF receptor 2 (VEGFR2/Flk1/KDR) have a very important role in the formation of the cardiovascular system (27). Other investigations have also reported that disturbances in the vascular formation and function might be the contributing
factor in several female reproductive disorders, for example, recurrent miscarriage and implantation failure (12, 28, 29). The necessity of angiogenesis
in a successful pregnancy and RSA through VEGF and one of its receptors, KDR, has been proposed in multiple studies (11, 15, 30, 31). A report from Iran show that Q472H (rs1870377) was highly linked to intronic SNP (rs6838752) (23). We surveyed whether KDR polymorphisms,  including the Gln472His (A/T) SNP is a risk factor for RSA in southern Iran. The aim of this study was to evaluate KDR polymorphisms that have been previously studied for the association with RSA
risk. Our findings reveal that the KDR Gln472His (A/T) polymorphism is consistently associated with increased RSA risk and the allele A as the reference
allele shows significant differences between the case and control samples (p = 0.016). Present data are in agreement with association of Q472H and A-C-A-T-G haplotype in the KDR gene with susceptibility to miscarriage (11). Binding of VEGF to KDR triggers multiple downstream signaling cascades, including PI3  kinase-Akt, protein kinase C, mitogen-activated protein kinases, and eNOS pathways, and induce migration and proliferation of endothelial cells. Consequently, this stimulation proceeds angiogenesis (32). It is believed that the mentioned polymorphisms altered the biological activity of corresponded pathway (21, 33, 34). The position of Q472H polymorphism, regarding the phenotypic condition in the favor of the dominance of the T allele and this allele increases the risk of
abortion by 2.4 times. The Q472H SNP (rs1870377), is located in the exon 11 and covers the fifth Nterminal Ig-like domains within the extracellular region. The extracellular domain is essential for ligand binding. The substituted amino acid at the codon 472 reduc VEGF-binding efficiency of tyrosine receptor (KDR) (21). During embryonic development, the KDR expression is restricted to endothelial cells and encoded protein has a crucial role on endothelial growth. precursors. Studies in KDR knockout mice shows its vital roles in the developing of blood vessel networks (14, 18, 35).
Also it is shown, this substitution of Glutamine by Histidine increases VEGFR-2 protein phosphorylation thereafter micro vessel density increases among lung cancer cases (36).
However there some reports that contraindicate with this finding like study by Rah et al. who did not find the KDR polymorphism susceptibility to RSA in Taiwanese as wel as Korean cases. (20, 37).
Contradictory results between two Asiatic ethnic groups, may arise from various factors, including a different definition of patients and controls for each study and ethnic variation or a combination of them. However, the limited sample size in this study may be required to replicate with a larger sample size. Fine mapping of specific loci within VEGF/KDR and extra genic variants will be the future direction and will provide more information on the functional  SNPs in these two genes.
5. Conclusion
There is a significant correlation between Q472H polymorphism and related polymorphism in the KDR gene with the risk of RSA and it should take into account the RSA cases in the south of Iran.
Acknowledgments The authors acknowledge all their colleagues who collaborated in this study. This research was supported by the Islamic Azad University, Arsanjan,Iran.
Conflict of Interest
There is no conflict of interest in this article.
Type of Study: Original Article |

References
1. Carrington B, Sacks G, Regan L. Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 2005; 17: 591-597. [DOI:10.1097/01.gco.0000194112.86051.26] [PMID]
2. Stirrat GM. Recurrent miscarriage. Lancet 1990; 336: 673-675. [DOI:10.1016/0140-6736(90)92159-F]
3. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9: 1328-1332. [DOI:10.1093/oxfordjournals.humrep.a138703] [PMID]
4. Stirrat GM. Recurrent miscarriage. II: Clinical associations, causes, and management. Lancet 1990; 336: 728-733. [DOI:10.1016/0140-6736(90)92215-4]
5. Simpson JL, Golbus MS. Genetics in obstetrics and gynecology. 2nd Ed. Philadelphia: W.B. Saunders Inc; 1992: 181-200.
6. Rai R, Regan L. Recurrent miscarriage. Lancet 2006; 368: 601-611. [DOI:10.1016/S0140-6736(06)69204-0]
7. Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996; 66: 24-29. [DOI:10.1016/S0015-0282(16)58382-4]
8. Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997; 94: 8761-8766. [DOI:10.1073/pnas.94.16.8761] [PMID] [PMCID]
9. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676. [DOI:10.1038/nm0603-669] [PMID]
10. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001; 47: 617-623.
11. Su MT, Lin SH, Lee IW, Chen YC, Kuo PL. Association of polymorphisms/haplotypes of the genes encoding vascular endothelial growth factor and its KDR receptor with recurrent pregnancy loss. Hum Reprod 2011; 26: 758-764. [DOI:10.1093/humrep/deq401] [PMID]
12. Ferrara N, Davis-Smith T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25. [DOI:10.1210/edrv.18.1.0287] [PMID]
13. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23: 1011-1027. [DOI:10.1200/JCO.2005.06.081] [PMID]
14. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611. [DOI:10.1210/er.2003-0027] [PMID]
15. Reynolds LP, Redmer DA. Angiogenesis in the placenta. Biol Reprod 2001; 64: 1033-1040. [DOI:10.1095/biolreprod64.4.1033] [PMID]
16. Demir R, Kayisli UA, Seval Y, Celik-Ozenci C, Korgun ET, Demir-Weusten AY, et al. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta 2004; 25: 560-572. [DOI:10.1016/j.placenta.2003.11.011] [PMID]
17. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 2006; 312: 549-560. [DOI:10.1016/j.yexcr.2005.11.012] [PMID]
18. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376: 62-66. [DOI:10.1038/376062a0] [PMID]
19. Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, et al. The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization. PLoS One 2012; 7: e47158. [DOI:10.1371/journal.pone.0047158] [PMID] [PMCID]
20. Rah H, Jeon YJ, Lee BE, Choi DH, Yoon TK, Lee WS, et al. Association of kinase insert domain-containing receptor (KDR) gene polymorphisms with idiopathic recurrent spontaneous abortion in korean women. Fertil Steril 2013; 99: 753-760. [DOI:10.1016/j.fertnstert.2012.10.038] [PMID]
21. Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, et al. Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 2007; 50: 760-767. [DOI:10.1016/j.jacc.2007.04.074] [PMID]
22. Honarvar N, Sheikhha MH, Farashahi Yazd E, Pashaiefar H, Mohtaram S, Sazegari A, et al. KDR gene polymorphisms and idiopathic recurrent spontaneous abortion. J Matern Fetal Neonatal Med 2016; 29: 3737-3740. [DOI:10.3109/14767058.2016.1142966] [PMID]
23. Shahsavari S, Noormohammadi Z, Zare Karizi S. Association of kinase insert domain-containing receptor (KDR) gene polymorphism/ haplotypes with recurrent spontaneous abortion and genetic structure. Int J Reprod Biomed 2015; 13: 755-764. [DOI:10.29252/ijrm.13.12.755]
24. Giudice LC. Potential biochemical markers of uterine receptivity. Hum Reprod 1999; 14 (Suppl.): 3-16. [DOI:10.1093/humrep/14.suppl_2.3] [PMID]
25. Sharkey A. Cytokines and implantation. Rev Reprod 1998; 3: 52-61. [DOI:10.1530/ror.0.0030052] [PMID]
26. Kimber SJ, Spanswick C. Blastocyst implantation: the adhesion cascade. Semin Cell Dev Biol 2000; 11: 77-92. [DOI:10.1006/scdb.2000.0154] [PMID]
27. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005; 65: 550-563. [DOI:10.1016/j.cardiores.2004.12.002] [PMID]
28. Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S, Kudo T. Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum Reprod 2002; 17: 190-194. [DOI:10.1093/humrep/17.1.190] [PMID]
29. Goswamy RK, Williams G, Steptoe PC. Decreased uterine perfusion--a cause of infertility. Hum Reprod 1988; 3: 955-959. [DOI:10.1093/oxfordjournals.humrep.a136825] [PMID]
30. Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 2003; 110 (Suppl.): 8-10. [DOI:10.1016/S0301-2115(03)00168-4]
31. Daher S, Mattar R, Gueuvoghlanian-Silva BY, Torloni MR. Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reprod Immunol 2012; 67: 341-347. [DOI:10.1111/j.1600-0897.2012.01123.x] [PMID]
32. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem Sci 2003; 28: 488-494. [DOI:10.1016/S0968-0004(03)00193-2]
33. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 2004; 56: 953-959. [DOI:10.1203/01.PDR.0000145280.26284.B9] [PMID]
34. Galan A, Ferlin A, Caretti L, Buson G, Sato G, Frigo AC, et al. Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor. Ophthalmology 2010; 117: 1769-1774. [DOI:10.1016/j.ophtha.2010.01.030] [PMID]
35. Hiratsuka S, Kataoka Y, Nakao K, Nakamura K, Morikawa S, Tanaka S, et al. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF-receptor positive cells to the anterior portion of early embryos. Mol Cell Biol 2005; 25: 355-363. [DOI:10.1128/MCB.25.1.355-363.2005] [PMID] [PMCID]
36. Glubb DM, Cerri E, Giese E, Zhang W, Mirza O, Thompson EE, et al. Novel functional germline variants in the vascular endothelial growth factor receptor 2 gene and their effect on gene expression and microvessel density in lung cancer. Clin Cancer Res 2011; 17: 5257-5267. [DOI:10.1158/1078-0432.CCR-11-0379] [PMID] [PMCID]
37. Su MT, Lin SH, Chen YC. Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod Update 2011; 17: 803-812. [DOI:10.1093/humupd/dmr027] [PMID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb